Evidence mapPaperPMID 40851429Full record

ArticleEuropean journal of neurology2025

Uncovering Hidden Profiles: From Pain-Centric to Multi-Symptom Small Fiber Neuropathy.

Peyton J Murin, Nicholas F Schulze, Vivian D Gao, Manouela V Valtcheva, Stefanie Geisler

Abstract read
In one paragraph

Article in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Peyton J MurinDepartment of Neurology, Saint Louis University, Saint Louis, Missouri, USA.ORCID 0009-0008-0727-9565
Nicholas F SchulzeDepartment of Neurology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.ORCID 0009-0009-0132-7578
Vivian D GaoDepartment of Neurology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Manouela V ValtchevaDepartment of Neurology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Stefanie GeislerDepartment of Neurology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.

Funding

Washington University Institute of Clinical and Translational SciencesUL1TR002345 · WASHINGTON UNIVERSITY · 2025 to 2025
$9.3M
Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathyR37CA267905 · NCI · WASHINGTON UNIVERSITY · 2023 to 2025
$831k
NCATS NIH HHS UL1 TR002345NCI NIH HHS R37 CA267905NCI NIH HHS R37CA267905
6 · The paper itself

Abstract

background and purposeSmall fiber neuropathy (SFN), resulting from dysfunction and loss of peripheral unmyelinated and thinly myelinated nerve fibers, is traditionally characterized by distal skin pain and sensory loss. Patients often report additional symptoms, including muscle cramps, myalgias, fatigue, subjective weakness, and neuropathic itch, but the prevalence and intensity of these symptoms remain poorly defined. Current treatments-focused primarily on pain-are often ineffective, possibly due to substantial between-patient heterogeneity. This study aimed to characterize the symptomatic variability of SFN and determine whether patients can be stratified into clinically meaningful subgroups.

methodsDemographic, clinical, and laboratory data were analyzed from patients with skin biopsy-confirmed SFN (n = 203) and healthy controls (n = 30). SFN patients were clustered based on clinical features using unsupervised machine learning.

resultsFatigue-not neuropathic pain-was the most prevalent and intense symptom among patients with SFN. Muscle symptoms were as common and severe as neuropathic pain, while neuropathic itch was rare. Three distinct phenotypic clusters were identified: (1) an "algesic" group (~20%) with severe neuropathic pain and co-occurring intense symptoms; (2) a "myalgic" group (~60%) with prominent fatigue, myalgias, and subjective weakness but milder neuropathic pain; and (3) a "pauci-symptomatic" group with few, mild to moderate symptoms. Clusters differed by symptom profiles, disease duration, intraepidermal nerve fiber density, sex, and body mass index.

conclusionFatigue and muscle symptoms are highly prevalent in SFN and may rival pain in clinical importance. Identifying patient subgroups provides a foundation for stratified treatment approaches and improved disease management.

Indexed as

FatigueNeuralgiaSmall Fiber NeuropathyAdultAgedFemaleHumansMaleMiddle Agedbody mass indexclassificationfatiguemyalgiaperipheral nervous system diseases

Identifiers

PMID40851429
PMCPMC12375876

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.